Maimonides Medical Center-Pharmacy, Brooklyn, NY
Is Maimonides Medical Center-Pharmacy registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Maimonides Medical Center-Pharmacy hold a New York pharmacy license?
State pharmacy license records for New York are not checked: the Office of the Professions’ online verification search requires an access key and a check that the user is a person, and its bulk verification files are released only on request. This index reads only that state’s board actions.
Has Maimonides Medical Center-Pharmacy had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Jul 20, 2023) and 1 FMD-145 letter (Jul 20, 2023) for Maimonides Medical Center-Pharmacy. State board actions: no New York State Education Department action under this exact name and city was found in the New York State Education Department’s list of Board of Regents disciplinary actions against pharmacy establishments (actions dated Jan 14, 1994 to May 19, 2026) on Nov 8, 2026. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Maimonides Medical Center-Pharmacy
- Location
- Brooklyn, NY
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 2
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Jul 20, 2023
- FDA Data Dashboard inspections
- 1 inspection: 1 VAI; 2 published Form 483s
- Form 483 text on this page
- 1 Form 483, 2 observations
- State board records
- Not checked (license records); board actions matched: 0
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Maimonides Medical Center-Pharmacy, a 503A facility, with 4 dated actions.
| Document | |||
|---|---|---|---|
| Jul 20, 2023 | State referral letter | State Referral Letter Issued 07/20/2023 | FDA copy (archived) |
| Jul 20, 2023 | FMD-145 letter | FMD-145 Issued 07/20/2023 | Not linked by FDA |
| Mar 9, 2023 | Form 483 | 483 Issued 03/09/2023 | FDA copy (archived) |
| Jul 29, 2019 | Form 483 | 483 Issued 07/29/2019 | FDA copy (archived) |
A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Maimonides Medical Center - Pharmacy, Brooklyn, NY (FEI number 3015468054), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Mar 9, 2023 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3015468054 | 1199619 |
Form 483s FDA has published for this site
- Mar 9, 2023: Form 483 to Maimonides Medical Center - Pharmacy, published Jul 6, 2023. fda.gov
- Jul 29, 2019: Form 483 to Maimonides Medical Center - Pharmacy, published Nov 5, 2019. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Feb 14, 2023 to Mar 9, 2023: 2 observations
- Firm on the cover
- Maimonides Medical Center-Pharmacy, 4802 10th Ave, Brooklyn, NY 11219-2916
- FEI number
- 3015468054
- Establishment type on the cover
- Producer of Sterile and Non-Sterile Drug Products
- FDA district office on the cover
- 158-15 Liberty Avenue Jamaica, NY 11433
- Matched to this page by
- FEI number on the cover; linked from actions page, Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
Your facility design allowed the influx of poor quality air into a higher classified area.
Specifically, the Emergency Department (ED) Satellite Pharmacy unclassified "segregated compounding area" lacks adequate controls to ensure that an acceptable environment is maintained in and around the ISO 5 <Redacted B4> laminar flow hood to produce sterile drugs for in-patient use. The ED ISO 5 <Redacted B4> laminar flow hood is used to produce sterile drugs for in-patient immediate use including Amikacin Injectable (Equiv to: Amikin) 1000 mg/100 ml NS, Order # <Redacted B4>, <Redacted B4> (Ct MRN: <Redacted B4> observed prepared on 02/17/2023 at 1215, Expi1y: 02/18/2023 at 0020. The following objectionable conditions were observed in the ED Satellite Pharmacy.
a. An air-conditioner cassette with local manual temperature and fan speed control is fitted in the ceiling of the room above and adjacent to the ISO 5 <Redacted B4> !laminar flow hood. You have not demonstrated that air delivered by the air-conditioner does not enter the ISO 5 <Redacted B4> laminar flow hood.
b. ...
Observation 2
Sinks or drains were present in the cleanroom where the ISO 5 classified aseptic processing area was located.
Specifically, in the Medical Intensive Care Unit (MIClJ) satellite pharmacy unclassified "segregated compounding ai·ea" a sink with water supply is located approximately 1.2 meters (just outside the line of demarcation) from the ISO 5 <Redacted B4> laminar flow hood. The MICU ISO 5 <Redacted B4> laminar flow hood is used to produce sterile drugs with a 12-hour BUD for in-patient use. During the inspection on 02/15/2023 we observed the pharmacist using the sink within the MICU to wash his hands as paii of the personnel gowning process before performing aseptic operations in the ISO <Redacted B4> laminar flow hood to produce Phenylephrine Injection (Equiv to: Neo-Synephrine NS 100 mg/250 ml), Order # <Redacted B4> (Ct MRN: <Redacted B4> prepared on 02/15/2023 at 1515, Expiry : 02/16/2023 at 0315.
Linked 483s whose text is not shown
- Jul 29, 2019: FDA document 132286: its numbered observations could not be read reliably from the PDF text.
State board of pharmacy records
State pharmacy license records for New York are not checked: the Office of the Professions’ online verification search requires an access key and a check that the user is a person, and its bulk verification files are released only on request. This index reads only that state’s board actions. Board actions source.
What this covers: Board of Regents disciplinary actions against pharmacy establishments from the Office of the Professions’ summaries for the pharmacy profession, which start in 1994 (105 of 105 list pages read). These are final Regents actions, mostly consent orders; open complaints and charges not yet decided are not listed. Actions against individual pharmacists are not copied. New York pharmacy licenses and registrations are not checked. Actions in the data are dated Jan 14, 1994 to May 19, 2026.
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- New York State Education Department disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.